Neurophet partners with Beijing LADO Technology Intends to establish Joint Venture in China
October 30, 2024 | 20:00
Neurophet, an artificial intelligence (AI) solution company for brain disease, has secured a significant foothold to accelerate entry into the Chinese market.
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis'
October 15, 2024 | 20:00
Neurophet, an artificial intelligence (AI) solution company for brain disease, announced its collaboration with AriBio, a biopharmaceutical company developing therapies for neurodegenerative diseases, to develop next-generation platform for Alzheimer's diagnosis.
Mobile Version